Month: May 2014

  • Partnership to Test Genome-Driven Breast Cancer Therapies

    15 May 2014. Researchers at Indiana University’s medical school in Indianapolis and Paradigm, a genomic sequencing company in Ann Arbor, Michigan are enrolling patients in a clinical study testing the ability of genomic sequencing to find optimal treatments for an aggressive type of breast cancer. The study covers women with triple-negative breast cancer, a form…

  • Trial Shows Polymer Dressing Reduces Surgical Scarring

    15 May 2014. A follow-up study of patients one year after cosmetic surgery shows a polymer adhesive dressing applied after the surgery reduced the formation of scars compared to untreated areas of the incision. The researchers tested the bandage made by Neodyne Biosciences of Menlo Park, California, and reported the results online earlier this month…

  • Biopharm Starts Genetic Heart Disease Clinical Database

    14 May 2014. MyoKardia Inc., a biopharmaceutical company in South San Francisco, California, began a repository of clinical data on patients with genetic heart disorders. The database, known as Sarcomeric Human Cardiomyopathy Registry, or SHaRe, is a joint project with seven medical centers specializing in these conditions in the U.S., U.K., Netherlands, and Italy. SHaRe aims…

  • Bayer, Boehringer Ingelheim Open Clinical Trial Data

    14 May 2014. Two more pharmaceutical companies, Bayer HealthCare and Boehringer Ingelheim, are making detailed data from clinical trials available to the larger scientific community. The two companies join several other pharmaceutical companies taking similar actions over the past several months. Bayer HealthCare in Leverkusen, Germany is making its trial data available through the joint industry…

  • Electronic Circuits Developed That Become Flexible in Body

    13 May 2014. Engineers and material scientists from University of Texas in Dallas and University of Tokyo in Japan developed electronic circuits encased in polymers that become flexible and adapt their shape to three-dimensional objects when implanted in mammals. The team from the labs of Walter Voit in Dallas and Takao Someya in Tokyo published…

  • Antioxidant-Rich Diets Fail to Reduce Heart Disease, Cancer

    13 May 2014. In a study of Italians age 65 and older, researchers at Johns Hopkins University in Baltimore find people with diets high in the antioxidant resveratrol — found in berries, dark chocolate, and red wine — develop cardiac problems and cancer, and live no longer than people who consume smaller amounts. A team…

  • Neurodegenerative Therapies Start-Up Gains $4.8M Seed Funds

    12 May 2014. Lysosomal Therapeutics Inc., a start-up developer of therapies for neurodegenerative disorders in Cambridge, Massachusetts, raised $4.8 million in seed financing, the enterprise’s initial operating funds. The company was begun by and is based on the research of Dimitri Krainc, a neurologist at Harvard Medical School and Massachusetts General Hospital in Boston. Atlas…

  • Heart Disease in Lab Recreated with Stem Cells, Chip Device

    12 May 2014. Medical and engineering researchers from Harvard University and affiliated hospitals created heart tissue with a genetic disorder on a chip-like device in the lab using stem cells. The results point to a new method for personalized lab testing of therapies for cardiac patients with cells derived from their own tissue, as well…

  • 1.1M Health Center Patients Left Uninsured in Opt-Out States

    9 May 2014. A new report estimates some 1.1 million clients of community health centers will be left without health insurance in U.S. states that choose not to expand Medicaid, as permitted under the Affordable Care Act. The report was prepared by the School of Public Health at George Washington University in Washington, D.C. A…

  • Remote Device Monitoring Linked to Higher Survival Rates

    9 May 2014. A study of more than 260,000 patients with implanted heart devices shows those who took part in frequent remote monitoring by device maker St. Jude Medical, also had more than twice the survival rate of patients without remote monitoring. The findings from the study, which show a correlation and not necessarily cause-and-effect,…